Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 16;27(10):110938.
doi: 10.1016/j.isci.2024.110938. eCollection 2024 Oct 18.

A regulatory loop involving the cytochrome P450-soluble epoxide hydrolase axis and TGF-β signaling

Affiliations

A regulatory loop involving the cytochrome P450-soluble epoxide hydrolase axis and TGF-β signaling

Xiaoming Li et al. iScience. .

Abstract

Fatty acid metabolites, produced by cytochrome P450 enzymes and soluble epoxide hydrolase (sEH), regulate inflammation. Here, we report that the transforming growth factor β (TGF-β)-induced polarization of macrophages to a pro-resolving phenotype requires Alk5 and Smad2 activation to increase sEH expression and activity. Macrophages lacking sEH showed impaired repolarization, reduced phagocytosis, and maintained a pro-inflammatory gene expression profile. 11,12-Epoxyeicosatrienoic acid (EET) was one altered metabolite in sEH-/- macrophages and mimicked the effect of sEH deletion on gene expression. Notably, 11,12-EET also reduced Alk5 expression, inhibiting TGF-β-induced Smad2 phosphorylation by triggering the cytosolic translocation of the E3 ligase Smurf2. These findings suggest that sEH expression is controlled by TGF-β and that sEH activity, which lowers 11,12-EET levels and promotes TGF-β signaling by metabolizing 11,12-EET to prevent Alk5 degradation. Thus, an autocrine loop between sEH/11,12-EET and TGF-β1 regulates macrophage function.

Keywords: Biochemistry; Cell biology; Molecular biology; Omics; Transcriptomics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interests.

Figures

None
Graphical abstract
Figure 1
Figure 1
Consequence of impaired sEH activity on the resolution of inflammation and sEH expression in macrophages (A) Cells present in peritoneal fluid from wild-type and sEH−/− mice up to 6 days after a single intraperitoneal injection of zymosan A (10 mg/kg). Neutrophils, Res. MØ, resident macrophages; Rec. MØ, recruited macrophages; DCs, dendritic cells; n = 5–6 animals per group. (B and C) Ephx2 RNA (B) and sEH protein (C) in murine bone-marrow-derived macrophages under basal conditions M0 (Sol) and after polarization to the M1, M2a, or M2c states; n = 6 mice per group. M2c macrophages from sEH−/− mice were included as a negative control. (D) Concentration-dependent effects of TGF-β1 (48 h) on sEH expression in M1-polarized murine macrophages; n = 5 mice per group. (E) sEH activity in polarized macrophages; n = 5 independent experiments. M2c-polarized macrophages from sEH−/− mice were included as a negative control. Error bars = SEM, (A) Two-way ANOVA followed by Sidak’s multiple comparisons test; (B–E) one-way ANOVA and Tukey’s multiple comparisons test. ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
Figure 2
Figure 2
Consequence of impaired sEH activity on macrophage phagocytosis and polarization (A and B) pHrodo Red Zymosan uptake by M2c-polarized macrophages from (A) wild-type (WT) and sEH−/− (−/−) mice or (B) from WT M2c macrophages treated with solvent or an sEH inhibitor (sEH-I, t-AUCB, 5 μmol/L); scale bar = 200 μm; n = 12 mice per group. (C) Oxidized LDL (ox-LDL) uptake by M2c-polarized macrophages from WT and sEH−/− mice; scale bar = 50 μm; n = 10 mice per group. (D) Expression marker genes in bone-marrow-derived macrophages from wild-type (WT) and sEH−/− (−/−) mice under basal conditions (M0) and following M1, M2a, and M2c polarization; n = 5–6 mice per group. Error bars = SEM, (A–C) Student’s t test; (D) two-way ANOVA followed by Sidak’s multiple comparisons test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001.
Figure 3
Figure 3
Role of ALK5-Smad2 pathway in the regulation of sEH expression by TGF-β1 (A) Effect of TGF-β1 (10 ng/mL) on the phosphorylation of SMAD2 (p-SMAD2) and SMAD1/5 (p-SMAD1/5) in M1-polarized murine macrophages; n = 5–6 mice per group. (B) Expression of Snail and Id3 in M2c-polarized macrophages; n = 5–6 mice per group. (C) Consequence of ALK1 inhibition (ALK1i) with LDN193189 (1 nmol/L) and ALK5 inhibition (ALK5i) with SD208 (500 nmol/L) on the TGF-β1-induced increase in sEH expression in murine macrophages; n = 5–6 mice per group. (D) Effect of TGF-β1 (10 ng/mL, 24 h) on sEH promoter activity in HEK cells; n = 6 independent experiments. (E) ChIP-qPCR analysis of SMAD2 binding to human sEH promoter in M1-polarized human macrophages stimulated with TGF-β1 (10 ng/mL, 24 h); n = 5–6 donors. (F) Effect of decoy oligonucleotides directed against SMAD2 and SP1 on the TGF-β1-induced increase of sEH expression in murine M1 macrophages; n = 5–6 mice per group. (G and H) Expression of Ephx2 (g) and sEH (h) in M2c-polarized macrophages from wild-type (WT) and SMOC1+/− (+/−) littermates; n = 6 mice per group. Error bars = SEM, (A) One-way ANOVA followed by Turkey’s multiple comparisons test; (B, C, E, G, and H) Student’s t test; (D and F) two-way ANOVA followed by Sidak’s multiple comparisons test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
Figure 4
Figure 4
RNA-seq analysis and validation (A) Volcano plot showing differential gene expression in M2c macrophages from wild-type and sEH−/− mice; n = 3 mice per group. Significantly regulated genes are indicated in blue (higher in sEH−/−) and green (higher in wild-type). (B) Heatmap showing the top 50 differentially expressed genes (Z scores) as in (A). (C–E) Bone-marrow-derived monocytes from WT and sEH−/− mice were differentiated to M0, M1, or M2c macrophages. Nlrp3 gene expression (C), Nlrp3 protein levels (D), and IL-1β levels in the cell supernatant (E); n = 4–5 mice per group. (F) Heatmap showing most differentially regulated inflammation- and resolution-related transcripts in cells from peritoneal fluid 6 days after zymosan administration; n = 4–5 mice per group. (G) Expression of Tlr2 and Mrc1 in M2c-polarized macrophages from wild-type (WT) and sEH−/− (−/−) mice; n = 5–6 mice per group. (H) Tlr2 and Mrc1 in macrophages from wild-type mice polarized to M2c in the presence of solvent (Sol) or an sEH inhibitor (sEH-I); n = 5–6 mice per group. (I) Tlr2 and Mrc1 expression in M2c-polarized macrophages from sEH−/− mice overexpressing either GFP, the wild-type sEH (WT), or a catalytically inactive sEH mutant (ΔEH); n = 5–6 mice per group. Error bars = SEM, (C–E) Two-way ANOVA followed by Tukey’s multiple comparisons test; (G and H) Student’s t test; (I) one-way ANOVA followed by Turkey’s multiple comparisons test. ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
Figure 5
Figure 5
PUFA mediator profiling in human macrophages (A) PUFA mediator levels in M1- and M2c-polarized human-monocyte-derived macrophages; n = 6–7 donors per group. Red = significantly elevated in M2c, blue = significantly elevated in M1, gray = non-significant. (B) PUFA mediator levels in human macrophages polarized from M1 to M2c in the presence of solvent (Sol) or the sEH inhibitor (t-AUCB, 10 μmol/L); n = 6–7 donors per group. (C) Effect of the selected arachidonic acid (AA) and linoleic acid (LA) epoxide (E)-diol (D) pairs, i.e., 11,12-EET/DHET and 9,10-EpOME/DiHOME (all 1 μmol/L, 48 h) on Tlr2 and NLRP3 expression in M1-polarized human macrophages; n = 4 donors. (D) Impact of 11,12-EET (E) and 11,12-DHET (D; both 1 μmol/L, 48 h) on the expression of Tlr2 and Nlrp3. Experiments were performed in the absence and presence of the EET antagonist 14,15-epoxyeicosa-5(Z)-enoic acid (EEZE; 1 μmol/L); n = 5 donors. Error bars = SEM, (C and D) One-way ANOVA followed by Turkey’s multiple comparisons test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
Figure 6
Figure 6
Effect of altered sEH expression on TGF-β signaling (A) Snai1 expression in M2c macrophages from wild-type (WT) and sEH−/− (−/−) mice; n = 4 animals per group. (B) TGF-β-stimulated phosphorylation of Smad2 in M1-polarized macrophages; n = 5 animals per group. (C) Expression of Alk5, Alk1, and TgfβrII in M1-polarized macrophages; n = 6 animals per group. (D and E) Impact of sEH inhibition (sEH-I) on the TGF-β (15 min)-induced phosphorylation of SMAD2 phosphorylation in M1 macrophages from wild-type mice (D) and expression of Alk5 (e); n = 5 animals per group. (F) Alk5 expression in M1 and M2c macrophages in the absence and presence of MG132; n = 5 mice per group. The image shows non-adjacent lanes from the same blot with the excised section indicated by a break. (G) Nuclear (n) and cytoplasmic (c) levels of Smurf2 in cells treated with Solvent (0.1% DMSO) or 11,12-EET (3 mmol/L) scale bar = 10 μm; n = 6 animals per group. (H) Consequence of siRNA-mediated Smurf2 knockdown on Alk5 expression in M1 macrophages; comparable results were obtained using an additional three animals per group. Error bars = SEM, A, C, D, E, and G) Student’s t test; (B and F) two-way ANOVA followed by Sidak’s multiple comparisons test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.

References

    1. Fleming I. The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease. Pharmacol. Rev. 2014;66:1106–1140. doi: 10.1124/pr.113.007781. - DOI - PubMed
    1. Imig J.D., Cervenka L., Neckar J. Epoxylipids and soluble epoxide hydrolase in heart diseases. Biochem. Pharmacol. 2022;195 doi: 10.1016/j.bcp.2021.114866. - DOI - PMC - PubMed
    1. Smith K.R., Pinkerton K.E., Watanabe T., Pedersen T.L., Ma S.J., Hammock B.D. Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor. Proc. Natl. Acad. Sci. USA. 2005;102:2186–2191. doi: 10.1073/pnas.0409591102. - DOI - PMC - PubMed
    1. Deng Y., Edin M.L., Theken K.N., Schuck R.N., Flake G.P., Kannon M.A., DeGraff L.M., Lih F.B., Foley J., Bradbury J.A., et al. Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice. Faseb. J. 2011;25:703–713. doi: 10.1096/fj.10-171488. - DOI - PMC - PubMed
    1. Zhou Y., Liu T., Duan J.-X., Li P., Sun G.-Y., Liu Y.-P., Zhang J., Dong L., Lee K.S.S., Hammock B.D., et al. Soluble epoxide hydrolase inhibitor attenuates lipopolysaccharide-induced acute lung injury and improves survival in mice. Shock. 2017;47:638–645. doi: 10.1097/SHK.0000000000000767. - DOI - PMC - PubMed